Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Frazier Life Sciencesfrazierls.com · Low evidenceFrazier Life Sciences is a biotech investment firm that manages over $6.9 billion in assets across venture and public strategies. The firm partners with and builds companies developing novel therapeutics, having created over 25 companies and supported more than 75 FDA-approved drugs since 2015.
Parse Score